Randomized, placebo‐controlled study on the effects of intravenous GSK3858279 (anti‐CCL17) on a battery of evoked pain tests in healthy participants

Abstract C–C Motif Chemokine Ligand 17 (CCL17) is a chemokine that binds and signals through the G‐protein coupled CC‐chemokine receptor 4 and has been implicated in the development of inflammatory and arthritic pain. GSK3858279 is a high‐affinity, first‐in‐class, monoclonal antibody, binding specif...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yvonne Boyle, Hemme J. Hijma, Jamie Rees, Jagtar Nijjar, Eirini Panoilia, Yolanda Alvarez, Sarah Siederer, Emma Greening, Edward Emery, Kathy Abbott Banner, Geert Jan Groeneveld
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-09-01
coleção:	Clinical and Translational Science
Acesso em linha:	https://doi.org/10.1111/cts.13873
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!